Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Exome-Based Rare-Variant Analyses in CKD.

Cameron-Christie S, Wolock CJ, Groopman E, Petrovski S, Kamalakaran S, Povysil G, Vitsios D, Zhang M, Fleckner J, March RE, Gelfman S, Marasa M, Li Y, Sanna-Cherchi S, Kiryluk K, Allen AS, Fellström BC, Haefliger C, Platt A, Goldstein DB, Gharavi AG.

J Am Soc Nephrol. 2019 Jun;30(6):1109-1122. doi: 10.1681/ASN.2018090909. Epub 2019 May 13.

PMID:
31085678
2.

Diagnostic Utility of Exome Sequencing for Kidney Disease.

Groopman EE, Marasa M, Cameron-Christie S, Petrovski S, Aggarwal VS, Milo-Rasouly H, Li Y, Zhang J, Nestor J, Krithivasan P, Lam WY, Mitrotti A, Piva S, Kil BH, Chatterjee D, Reingold R, Bradbury D, DiVecchia M, Snyder H, Mu X, Mehl K, Balderes O, Fasel DA, Weng C, Radhakrishnan J, Canetta P, Appel GB, Bomback AS, Ahn W, Uy NS, Alam S, Cohen DJ, Crew RJ, Dube GK, Rao MK, Kamalakaran S, Copeland B, Ren Z, Bridgers J, Malone CD, Mebane CM, Dagaonkar N, Fellström BC, Haefliger C, Mohan S, Sanna-Cherchi S, Kiryluk K, Fleckner J, March R, Platt A, Goldstein DB, Gharavi AG.

N Engl J Med. 2019 Jan 10;380(2):142-151. doi: 10.1056/NEJMoa1806891. Epub 2018 Dec 26.

PMID:
30586318
3.

ADAMTS13 predicts renal and cardiovascular events in type 2 diabetic patients and response to therapy.

Rurali E, Noris M, Chianca A, Donadelli R, Banterla F, Galbusera M, Gherardi G, Gastoldi S, Parvanova A, Iliev I, Bossi A, Haefliger C, Trevisan R, Remuzzi G, Ruggenenti P; BENEDICT Study Group.

Diabetes. 2013 Oct;62(10):3599-609. doi: 10.2337/db13-0530. Epub 2013 Jun 3.

4.

Growth differentiation factor 15 predicts future insulin resistance and impaired glucose control in obese nondiabetic individuals: results from the XENDOS trial.

Kempf T, Guba-Quint A, Torgerson J, Magnone MC, Haefliger C, Bobadilla M, Wollert KC.

Eur J Endocrinol. 2012 Nov;167(5):671-8. doi: 10.1530/EJE-12-0466. Epub 2012 Aug 23.

PMID:
22918303
5.

Current drug development challenges in chronic kidney disease (CKD)--identification of individualized determinants of renal progression and premature cardiovascular disease (CVD).

Formentini I, Bobadilla M, Haefliger C, Hartmann G, Loghman-Adham M, Mizrahi J, Pomposiello S, Prunotto M, Meier M.

Nephrol Dial Transplant. 2012 Oct;27 Suppl 3:iii81-8. doi: 10.1093/ndt/gfs270. Epub 2012 Jun 25.

PMID:
22734108
6.

Comparative transcriptional network modeling of three PPAR-α/γ co-agonists reveals distinct metabolic gene signatures in primary human hepatocytes.

Deehan R, Maerz-Weiss P, Catlett NL, Steiner G, Wong B, Wright MB, Blander G, Elliston KO, Ladd W, Bobadilla M, Mizrahi J, Haefliger C, Edgar A.

PLoS One. 2012;7(4):e35012. doi: 10.1371/journal.pone.0035012. Epub 2012 Apr 13.

7.

DNA methylation of the PITX2 gene promoter region is a strong independent prognostic marker of biochemical recurrence in patients with prostate cancer after radical prostatectomy.

Weiss G, Cottrell S, Distler J, Schatz P, Kristiansen G, Ittmann M, Haefliger C, Lesche R, Hartmann A, Corman J, Wheeler T.

J Urol. 2009 Apr;181(4):1678-85. doi: 10.1016/j.juro.2008.11.120. Epub 2009 Feb 23.

PMID:
19233404
8.

IL-10 is excluded from the functional cytokine memory of human CD4+ memory T lymphocytes.

Dong J, Ivascu C, Chang HD, Wu P, Angeli R, Maggi L, Eckhardt F, Tykocinski L, Haefliger C, Möwes B, Sieper J, Radbruch A, Annunziato F, Thiel A.

J Immunol. 2007 Aug 15;179(4):2389-96.

9.

Third Santorini conference pharmacogenomics workshop report: "Pharmacogenomics at the crossroads: what else than good science will be needed for the field to become part of Personalized Medicine?".

Llerena A, Michel G, Jeannesson E, Wong S, Manolopoulos VG, Hockett RD, Boubekeur K, Siest G, Beaune P, Haefliger C, Arnold HP, Junien C, Petrovic N, Molloy R, Bekers O, Donnelly C, Arens HJ, Kaput J, McComb J.

Clin Chem Lab Med. 2007;45(7):843-50.

PMID:
17617025
10.

Discovery and validation of 3 novel DNA methylation markers of prostate cancer prognosis.

Cottrell S, Jung K, Kristiansen G, Eltze E, Semjonow A, Ittmann M, Hartmann A, Stamey T, Haefliger C, Weiss G.

J Urol. 2007 May;177(5):1753-8.

PMID:
17437806
11.

DNA methylation profiling of human chromosomes 6, 20 and 22.

Eckhardt F, Lewin J, Cortese R, Rakyan VK, Attwood J, Burger M, Burton J, Cox TV, Davies R, Down TA, Haefliger C, Horton R, Howe K, Jackson DK, Kunde J, Koenig C, Liddle J, Niblett D, Otto T, Pettett R, Seemann S, Thompson C, West T, Rogers J, Olek A, Berlin K, Beck S.

Nat Genet. 2006 Dec;38(12):1378-85. Epub 2006 Oct 29.

12.

Identifying DNA methylation biomarkers of cancer drug response.

Maier S, Dahlstroem C, Haefliger C, Plum A, Piepenbrock C.

Am J Pharmacogenomics. 2005;5(4):223-32. Review.

PMID:
16078859
13.

Prenatal diagnosis of a diploid-tetraploid fetus.

Montanari D, Haefliger C, Mollica ME, Bañares V, Zelaya G.

Acta Obstet Gynecol Scand. 2000 Nov;79(11):1026. No abstract available.

PMID:
11081693
14.

Formation of supernumerary euchromatic short arm isochromosomes: parent and cell stage of origin in new cases and review of the literature.

Eggermann T, Schubert R, Engels H, Apacik C, Stengel-Rutkowski S, Haefliger C, Emiliani V, Ricagni C, Schwanitz G.

Ann Genet. 1999;42(2):75-80. Review.

PMID:
10434120

Supplemental Content

Loading ...
Support Center